Francisella Lipids Modulate Immune Response Without Suppressing Adaptive Pathogen Clearance
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current anti-inflammatory treatments for viral infections often inhibit the overall immune response, disrupting adaptive immune responses and leading to poor pathogen clearance, particularly in cases of Francisella tularensis infections which induce anti-inflammatory responses and cause severe diseases like tularemia.
Innovation Solution
Development of a composition comprising purified lipids from Francisella tularensis, specifically phosphatidylethanolamine (PE) and phosphatidylcholine (PC) lipids, which modulate the immune response to induce an anti-inflammatory effect without disrupting adaptive immune responses, formulated into liposomes for effective treatment and prevention of infections.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If conventional anti-inflammatory treatments are used during viral infection, then inflammation is reduced, but the overall immune response is greatly inhibited and adaptive immune responses are disrupted
Solution Approach 1:
The patent extracts and isolates specific lipids (phosphatidylethanolamine and phosphatidylcholine) from Francisella tularensis to create a targeted anti-inflammatory composition. This extracted lipid composition provides anti-inflammatory effects without the broad immunosuppression caused by conventional anti-inflammatory treatments, thereby resolving the contradiction between reducing inflammation and maintaining adaptive immune response.
2Object-affected harmful factors
If anti-inflammatory responses are induced during Francisella infection, then inflammation is controlled, but pathogen clearance ability is impaired
Solution Approach 1:
The patent changes the parameter of immune modulation by using specific bacterial lipids that selectively modulate the immune response. The lipid composition alters the balance between anti-inflammatory effects and pathogen clearance capability, achieving inflammation control while preserving the immune system's ability to clear pathogens through adaptive immune responses.
Data Source
AI summary
Embodiments of the present disclosure include anti-inflammatory compositions and methods of use thereof. The compositions include purified lipids from Francisella, for example, virulent strains of Francisella. Other features and advantages of the invention will be apparent from the detailed description, and from the claims.